Skip to main content
. 2021 Aug 16;91(7):1812–1820. doi: 10.1038/s41390-021-01611-6

Fig. 6. IL-1β, NLRP3, IRAK4, MyD88 and TRIF children with DS compared to controls.

Fig. 6

Fold-change expression of IL-1β (a), and NLRP3 (b), in whole-blood samples from children with DS (n = 18) compared to control samples (n = 10), and of MyD88 (c), IRAK4 (d), TRIF (e), in children with DS (n = 10) and controls (n = 10) at baseline and following treatment with LPS and melatonin. Statistical significance is *p < 0.05.